Home  /  Resource Library  /  Characteristics and Clinical Outcomes of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma who Received at Least 3 Lines of Therapies

Characteristics and Clinical Outcomes of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma who Received at Least 3 Lines of Therapies

Study examined characteristics of patients with relapsed DLBCL.